N-Methyl Peptide Library Construction via Cell-Free Translation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current peptide libraries lack sufficient variety and properties to effectively identify new pharmaceutical agents, particularly due to their restriction to natural linear or disulfide-linked peptides, which limits the development of non-standard peptides with enhanced membrane permeability and target binding capacity.
Innovation Solution
A method for constructing a non-standard peptide library using a cell-free translation system that incorporates multiple N-methyl amino acids and combines genetic code reassignment technology with an in vitro display system to select peptides with high binding affinity to target proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional peptide libraries using natural linear peptides are used, then the library construction is simple and cost-effective, but the membrane permeability and target binding capacity are insufficient
Solution Approach 1:
The patent modifies the chemical structure of amino acid residues by introducing N-methyl groups at specific positions within the peptide sequence. This parameter change in the molecular structure enhances membrane permeability while maintaining the ability to bind to target proteins, thereby resolving the contradiction between ease of manufacture and biological activity.
Solution Approach 2:
The patent creates composite peptide structures by combining natural amino acids with N-methyl modified amino acids in specific patterns. This composite approach allows the peptide to simultaneously exhibit good membrane permeability (from the N-methyl groups) and high target binding affinity (from the natural amino acid residues), overcoming the limitations of conventional homogeneous peptide libraries.
2Reliability
If non-standard peptides with enhanced properties are developed, then membrane permeability and target binding capacity improve, but the library construction complexity and cost increase
Solution Approach 1:
The patent employs FACS (Fluorescence-Activated Cell Sorting) to pre-select and enrich peptide variants with desirable properties before final library construction. This preliminary selection step reduces the complexity of subsequent library generation by focusing resources on pre-validated sequence patterns that already demonstrate enhanced membrane permeability and target binding.
Solution Approach 2:
The patent identifies successful N-methyl peptide sequences and creates multiple copies or variants of these proven designs. By copying and iteratively optimizing successful patterns rather than de novo library construction, the method reduces overall complexity while maintaining high reliability of the final peptide library.
3Stability of the object's composition
If N-methyl amino acids are incorporated into the peptide library, then protease resistance and membrane permeability are improved, but the synthesis difficulty and cost increase
Solution Approach 1:
The patent introduces N-methyl modifications at specific local positions within the peptide sequence rather than uniformly across all residues. This localized modification strategy provides protease resistance at critical sites while minimizing the overall synthesis complexity and cost, as only specific positions require the more expensive N-methyl amino acid incorporation.
Solution Approach 2:
The patent incorporates N-methyl amino acids at selected positions rather than in every residue, applying partial action where it provides maximum benefit for protease resistance. This selective approach balances the increased synthesis difficulty and cost against the substantial improvement in protease stability, avoiding the excessive cost of complete N-methyl substitution.
Data Source
Figure 1
Figure 2-1
Figure 2-2
AI summary
A method for screening a non-standard peptide compound in the peptide library that binds to the target substance, comprising the steps: (i) preparing a non-standard peptide library wherein a special (non-standard) amino acid is randomly incorporated into the peptide sequence by a cell-free (in vitro) translation system comprising a tRNA acylated by a special (non-standard) amino acid; (ii) bringing the obtained peptide library in contact with a target substance; and (iii) selecting a non-standard peptide that binds to the target substance as an active peptide.